Noticias June 06, 2026 Study shows BAS therapies can decrease and delay recurrent pouchitis Mayo Clinic researchers found that patients treated with bile acid sequestrant therapies had a lower rate of recurrence compared with patients treated with standard antibiotics. June 06, 2026 Research finds JAK inhibitors don't increase risks for patients with IBD A Mayo Clinic study focused exclusively on patients with inflammatory bowel disease offers novel reassurance for patients seeking rapid and targeted immunomodulation. June 06, 2026 Resetting the diaphragm: Durable management of severe abdominal distention Diaphragmatic exercises with biofeedback can benefit patients with abdominophrenic dyssynergia. Mayo Clinic Gastroenterology and Hepatology specialists teach patients this equipment-free approach. June 04, 2026 Strategies for reoperative Crohn's disease and ulcerative colitis The expertise and advanced techniques of Mayo Clinic surgeons optimize outcomes for reoperative Crohn's disease and ulcerative colitis. April 14, 2026 Addressing challenges associated with complex pelvic tumors Mayo Clinic brings together specialized surgeons, advanced imaging and coordinated care to treat pelvic tumors and recurrent rectal cancer that many centers consider inoperable. March 10, 2026 Gastric fundal mucosal ablation targets hormonal causes of obesity Mayo Clinic surgeons pair gastric fundal mucosal ablation with endoscopic sleeve gastroplasty to achieve optimal weight-loss outcomes. March 10, 2026 Clinical impact of endoscopic bariatric therapies to treat MASLD Mayo Clinic gastroenterologists perform endoscopic bariatric procedures, such as endoscopic sleeve gastroplasty and intragastric balloon, to help treat MASLD. Jan. 07, 2026 PRETREAT score provides clinicians with an evidence-based tool to guide post-transplant management of pCCA The Perihilar Cholangiocarcinoma Risk Estimation of Tumor Recurrence After Transplant (PRETREAT) score is designed to facilitate individualized surveillance strategies and the development of adjuvant therapy. Jan. 07, 2026 AI-based ACE score accurately predicts decompensation and liver outcomes in patients diagnosed with cirrhosis This artificial intelligence-based noninvasive tool enhances current prognostic models and may improve risk stratification in cirrhosis management. Jan. 07, 2026 Use of simultaneous liver transplant and sleeve gastrectomy in managing patients with obesity and end-stage liver disease Durable weight loss, improved metabolic syndrome and reduced allograft steatosis were among the outcomes associated with the combined surgeries. Jan. 07, 2026 Human liver disease and the evolving role of CRISPR/Cas9 In this Q&A, Kirk J. Wangensteen, M.D., Ph.D., explains how researchers are using CRISPR/Cas9 to study and develop new therapies for human liver diseases. Nov. 25, 2025 Nonendoscopic screening tools for early detection of Barrett's esophagus, esophageal adenocarcinoma and dysplasia The need for less invasive screening tools to detect esophageal cancer has prompted researchers to study microRNA and biomarker technology to detect Barrett's esophagus (BE), esophageal adenocarcinoma (EAC) and dysplasi[...] Oct. 01, 2025 Examining the incidence, clinical features and outcomes of small bowel neoplasms in individuals with Crohn's disease Nonpenetrating/nonstricturing and stricturing-only Crohn's disease was associated with increased odds of SBN, while penetrating disease did not seem to be a risk factor. Oct. 01, 2025 Examining the impact of herpes zoster (HZ) and HZ vaccination in patients with IBD Recent research findings demonstrate the benefits associated with the two-dose recombinant HZ vaccine in adults with IBD. Oct. 01, 2025 Comparing intestinal barrier function in patients with Crohn's disease or ulcerative colitis and healthy controls The researchers observed impaired intestinal barrier function in patients with active Crohn's disease or ulcerative colitis that persists during remission. Oct. 01, 2025 Examining the real-world effectiveness and safety of risankizumab in patients with Crohn's disease Researchers shared real-world effectiveness data and demonstrated how RZB performs in patients with prior therapy exposure and other clinical factors. Sept. 16, 2025 How surgical innovation has changed the standard of care for locally advanced colorectal cancer Mayo Clinic surgeons use the latest surgical procedures to achieve complete tumor removal for locally advanced colorectal cancers that were once deemed unresectable. Aug. 22, 2025 Modified proximal gastrectomy offers benefits for locally advanced GEJ adenocarcinoma Modified proximal gastrectomy with double tract reconstruction is a promising alternative to total gastrectomy, offering improved nutrition and quality of life for patients with locally advanced GEJ adenocarcinoma. July 29, 2025 Surgery remains an important treatment option for pediatric inflammatory bowel disease (IBD) New medications have improved pediatric IBD care, but surgery is still an important option to cure ulcerative colitis and reduce Crohn's disease symptoms. July 22, 2025 Update on therapeutic endoscopic ultrasound Review article co-authors share detailed information about endoscopic ultrasound (EUS)-guided access and antegrade stenting, direct EUS-guided drainage, and EUS-guided luminal anastomosis. July 22, 2025 Examining the impact of endoscopic resection approach on intestinal metaplasia and dysplasia recurrence after complete remission: EMR versus ESD Endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) appear to have comparable rates of Barrett's esophagus (BE) or dysplastic BE recurrence. July 22, 2025 Examining the impact of GLP-1 receptor agonist use on quality of bowel preparation for colonoscopy A study of more than 6,000 patients suggests that these medications are associated with worse bowel preparations, with negative effects on colorectal cancer screening and surveillance. July 22, 2025 Examining Alaska Native peoples' perspectives about options for colorectal cancer screening Survey results provided valuable insights into the complex factors influencing colorectal cancer (CRC) screening preferences in high-risk, remote populations. April 01, 2025 Use of AI-equipped application to help review bile duct brushing cytologic specimens The tool is designed to assist cytologists in the evaluation of digital whole-slide images generated from bile duct brushing specimens. April 01, 2025 Validation study examines accuracy of the GALAD score algorithm for diagnosing HCC in sub-Saharan Africans Researchers are hopeful that this algorithm could enhance early detection and surveillance and lead to improved survival rates in regions with limited resources. April 01, 2025 Prospective multicenter study tests combination of pancreatic juice and blood-based biomarkers to facilitate early pancreatic cancer detection A combination of methylated DNA biomarkers in pancreatic juice and plasma carbohydrate antigen 19-9 detected pancreatic ductal adenocarcinoma with higher accuracy compared to either stand-alone. Jan. 08, 2025 Incidence of gastric cancers and associated risk factors in patients with familial adenomatous polyposis The researchers shared findings that could help refine surveillance guidelines to improve detection rates and guide timely intervention for potentially malignant lesions. Jan. 08, 2025 Use of artificial intelligence tools and electronic health record data for pancreatic cancer risk prediction Shounak Majumder, M.D., summarizes the significance of studies using machine learning and natural language processing to accurately delineate PC risk and identify novel risk factors. Jan. 08, 2025 Nonendoscopic detection of Barrett esophagus by methylated DNA markers The study results demonstrate that nonendoscopic detection of BE using methylated DNA markers and a locked algorithm is an accurate, safe and well-tolerated alternative to sedated esophagogastroduodenoscopy. Oct. 22, 2024 Examining the prevalence of FI and its relationship with age, sex and geographic location in adults The systematic review and meta-analysis sheds light on the prevalence of FI and its relationship with age, sex and geographic location in adults. Oct. 22, 2024 An updated appraisal of the SIBO hypothesis and the limits of breath testing Review article authors assert that breath testing for small intestinal bacterial overgrowth in patients with irritable bowel syndrome yields a high number of false positives. Oct. 22, 2024 Assessing the effectiveness and safety of virtual reality in treating functional dyspepsia This first-ever, randomized, controlled pilot study assessed participants' symptoms and quality of life over a two-week period. Oct. 22, 2024 Examining the prevalence of low vitamin D levels in patients with gastroparesis and its relationship to symptoms Study data from a group of 513 patients also showed that low vitamin D levels are associated with nausea, vomiting and gastric neuromuscular dysfunction. Aug. 27, 2024 Parastomal hernia repair: Helping patients return to their everyday activities A specialized Mayo Clinic team repairs parastomal hernias, complications arising in 50% of patients postostomy. The team has substantial training and experience in this surgery and assists patients with their entire sto[...] Aug. 22, 2024 Fecal calprotectin assay performs well as biomarker for measurement of ulcerative colitis disease activity FC levels can accurately identify endoscopic and clinical remission and may reduce the need for frequent colonoscopies and associated risks. Aug. 22, 2024 J-pouch disorders: Classification and management In an American Journal of Gastroenterology publication, Mayo Clinic gastroenterologists discuss the most common disorders of the pouch, and recent research findings related to their evaluation and management. Aug. 22, 2024 Examining the efficacy of recombinant zoster vaccination in patients with IBD The study also examined the incidence of herpes zoster-related complications, and the impact of IBD medications and comorbidities on infection risks. June 26, 2024 The role of endoscopic techniques in addressing postbariatric surgery complications Mayo Clinic researchers share a comprehensive overview of the most common postoperative complications and the techniques and devices available to help manage them. June 26, 2024 Continued type 2 diabetes mellitus remission independent of weight loss observed in patients after Roux-en-Y gastric bypass Data from a retrospective study of 224 patients suggest that roux-en-Y gastric bypass can help patients sustain type 2 diabetes mellitus remission even when significant weight recurrence occurs. June 26, 2024 Assessing the prevalence and impact of obesity among individuals with Crohn's disease In a population-based study of individuals with newly diagnosed Crohn's disease (CD), researchers analyzed the prevalence of obesity and whether it affects disease phenotype and CD-related outcomes. June 26, 2024 Association between individualized metabolic surgery scores and weight-loss outcomes in patients treated with semaglutide Retrospective study examines associations between individualized metabolic surgery scores and weight-loss outcomes in patients treated with semaglutide for obesity and type 2 diabetes mellitus. May 08, 2024 Kefir may improve gut health of patients in the ICU Gut microbiome derangement is frequent in the ICU, potentially leading to a heightened risk of infections, organ failure, septic shock and mortality. A recent study assessed the safety, feasibility and impact of kefir a[...] April 13, 2024 Use of smartphone-enabled mood assessments and sensor data to predict alcohol craving in patients with alcohol-associated liver disease and alcohol use disorder Researchers identified specific patterns in smartphone-enabled mood assessments and sensor data that were associated with increased alcohol craving among patients with alcohol-associated liver disease and alcohol use di[...] April 13, 2024 Using machine learning algorithms to differentiate between acute cholangitis and alcohol-associated hepatitis Mayo Clinic researchers used data from 10 routinely available laboratory values to develop and train MLAs to help clinicians differentiate between the two conditions. Feb. 24, 2024 Profiling the human gastric muscle immunome in patients with idiopathic gastroparesis By profiling the human gastric muscle immunome in patients with idiopathic gastroparesis, researchers observed macrophage-driven changes and distinct patterns of human gastric muscle immune cells. Feb. 24, 2024 Small bowel endoluminal bariatric and metabolic therapies Mayo Clinic gastroenterologist Dilhana S. Badurdeen, M.B.B.S., M.D., discusses the duodenojejunal bypass sleeve, duodenal mucosal resurfacing, pharmacological duodenal exclusion therapy, duodenal mucosal electroporation[...] Feb. 24, 2024 Researchers study novel endoscopic therapy for type 2 diabetes Mayo Clinic gastroenterologist Andrew C. Storm, M.D., answers questions about the use of endoscopic re-cellularization via electroporation therapy (ReCET) in individuals with difficult-to-control type 2 diabetes. Jan. 11, 2024 Treating eosinophilic esophagitis with transnasal endoscopy Eosinophilic esophagitis is a chronic immune system disease where eosinophils build up in the lining of the esophagus. Mayo Clinic Children's Center offers a multidisciplinary approach, which includes an alternative to [...] Dec. 12, 2023 Use of machine learning models to predict Barrett esophagus and esophageal adenocarcinoma risk Researchers are hopeful that this model may enable effective implementation of minimally invasive screening technology for Barrett esophagus (BE) and esophageal adenocarcinoma (EAC). Dec. 12, 2023 Endoluminal bariatric and metabolic therapies: Part 1 — Endoscopic sleeve gastroplasty Researchers document the current state of EBMTs and clinical outcomes associated with these approaches. Dec. 12, 2023 Management of obesity within hepatology clinics Researchers discuss the role of dietary supplements, glucagon-like peptide 1 receptor agonists, sodium-glucose cotransporter-2 inhibitors and bariatric surgery in patients with gastrointestinal and liver diseases. Oct. 31, 2023 Analysis of patient outcomes after flexible endoscopic Zenker diverticulotomy Mayo Clinic researchers analyzed data from 84 procedures, noting patient demographics, clinical features, procedural characteristics, adverse events and outcomes. Oct. 31, 2023 Examining the efficacy and safety of CBD in patients with idiopathic and diabetic gastroparesis Mayo Clinic researchers observed that patients who received twice-daily doses of cannabidiol (CBD) had favorable outcomes in a placebo-controlled clinical trial with 44 participants. Oct. 31, 2023 Isolated bulb celiac disease in children Separating biopsies from the duodenal bulb and the distal duodenum enhances diagnostic sensitivity, especially in patients with lower celiac serology levels and disease isolated to the duodenal bulb. Aug. 19, 2023 Prior authorization process can have multiple negative impacts for gastroenterologists and patients with inflammatory bowel disease In a published letter to the editor, Mayo Clinic physicians discuss the impact of the prior authorization process and advocate for change that prioritizes evidence-based treatment decisions. Aug. 19, 2023 Scientific and clinical advances aid in diagnosis, staging and treatment of cholangiocarcinoma Sumera I. Ilyas, M.B.B.S., and colleagues highlight key areas of research that are helping clinicians better understand and treat cholangiocarcinoma. Aug. 19, 2023 Esophageal endoscopic submucosal dissection In this Q&A, Mayo Clinic gastroenterologist Norio Fukami, M.D., describes techniques and benefits associated with esophageal endoscopic submucosal dissection (ESD). June 16, 2023 Examining HBV vaccine efficacy and durability in individuals with IBD and celiac disease Low hepatitis B surface antigen antibody titers in fully vaccinated patients may not indicate a lack of immunity. June 16, 2023 Analyzing the impact of EHR use on gastroenterology providers A retrospective study examined electronic health record (EHR) use among gastroenterology specialists and whether provider sex, clinical subspecialty or training level was associated with increased EHR related burdens. June 16, 2023 Why gastroenterologists and hepatologists should be involved in treating obesity Mayo Clinic gastroenterologist Michael Camilleri, M.D., D.Sc., discusses the interplay between gastrointestinal and liver diseases and obesity, and the role of gastroenterologists in addressing these conditions. April 21, 2023 Examining the use of endoscopic bariatric therapy in patients with IBD Five individuals with inflammatory bowel disease (IBD) and obesity experienced effective weight loss after endoscopic bariatric therapy (EBT). April 21, 2023 Optimizing surveillance in patients with dysplastic Barrett esophagus after endoscopic eradication Study results suggest that lengthening surveillance intervals would reduce the burden of endoscopic procedures without increasing rate of recurrence. March 02, 2023 Early Mayo Clinic research finds hope in stem cell therapy for perianal fistulas in patients with Crohn’s disease Mayo Clinic researchers documented healing and few side effects in patients with single-tract fistulas who were treated with the bioabsorbable, surgically implanted plug. Feb. 11, 2023 Endoscopic retrograde cholangiography versus percutaneous transhepatic biliary drainage in liver transplant recipients with a Roux-en-Y biliary-enteric anastomosis Study data suggest that endoscopic retrograde cholangiography (ERC) and percutaneous transhepatic biliary drainage (PTBD) have comparable effectiveness in this patient population. Feb. 11, 2023 Impact of ESG on weight loss, gastric emptying, gastric motility, obesity-related hormones and eating behaviors Study results suggest that ESG can lead to greater weight loss, while preserving gastric motility and favorable changes in gastric emptying and obesity-related hormones. Dec. 15, 2022 Addressing the rising incidence of early-onset colorectal cancer Mayo Clinic gastroenterologist Frank A. Sinicrope, M.D., analyzes current evidence related to the phenotype and diagnosis of early-onset colorectal cancer and strategies to address the increasing incidence of this disea[...] Dec. 15, 2022 Understanding the needs and burdens of patients with CIC and IBS-C Identifying these issues helps clinicians understand patients' experiences and develop effective treatment strategies. Dec. 15, 2022 Treatment of recurrent CDI: Examining the efficacy and safety of standardized live biotherapeutics as microbiota restoration therapies Mayo Clinic gastroenterologist Sahil Khanna, M.B.B.S., M.S., discusses two microbiota restoration therapies for treatment of recurrent Clostridioides difficile infection. Dec. 15, 2022 Gastrointestinal manifestations of common variable immunodeficiency Mayo Clinic gastroenterologists discuss clinical presentations, diagnostic considerations and therapeutic options for the GI manifestations of common variable immunodeficiency (CVID). Oct. 20, 2022 Exploring the use of MRE and liver stiffness measurement to guide treatment and predict outcomes in patients with NAFLD Study suggests that liver stiffness measurement obtained through magnetic resonance elastography (MRE) can help individualize care and predict outcomes in patients with nonalcoholic fatty liver disease. Oct. 20, 2022 Examining the efficacy of CBD in patients with functional dyspepsia and normal gastric emptying A randomized, double-blind, controlled trial showed that symptom relief associated with cannabidiol (CBD) and placebo were not significantly different. Oct. 20, 2022 Large, multicenter randomized clinical trial examines the safety and efficacy of ESG Endoscopic sleeve gastroplasty (ESG), combined with lifestyle modifications, is a safe intervention that can help patients achieve and maintain significant weight loss and improvements in metabolic comorbidities. Aug. 19, 2022 Health care maintenance in patients with IBD Following preventive care recommendations is extremely important in the management of patients with inflammatory bowel disease. Aug. 19, 2022 Procedural and anthropometric factors associated with musculoskeletal injuries among gastroenterology endoscopists Findings reveal increasing rates of musculoskeletal symptoms and injury among endoscopists, many of which are significant enough to affect their daily function. Aug. 19, 2022 Management of short bowel syndrome in adult patients Adult patients diagnosed with this complex condition can benefit from nutritional support, fluid and electrolyte management, pharmacologic therapies, and surgery provided by an experienced team. Aug. 19, 2022 Factors related to jaundice and transplant-free survival in patients with PSC who receive endoscopic treatment The likelihood of resolution is affected by demographic, hepatic and biliary variables and can be predicted using noninvasive data. June 17, 2022 Examining the use of ETO gas sterilization and high-level disinfection on EUS imaging equipment Addition of ethylene oxide (ETO) gas sterilization to the disinfection process for endoscopic ultrasound (EUS) equipment does not appear to degrade image and video quality. June 17, 2022 Use of comprehensive multigene panel testing for patients with HBC Data from Mayo Clinic's INTERCEPT trial suggests that germline testing should be considered in all patients with hepatobiliary cancer (HBC). June 17, 2022 Convolutional neural network detects and estimates severity of cirrhosis using ECG findings A deep learning-based artificial intelligence model using convolutional neural networks to analyze 12-lead electrocardiograms (ECGs) performed well in detecting the presence and severity of hepatic cirrhosis. April 19, 2022 Evaluation and management of small bowel bleeding Mayo Clinic gastroenterologists discuss the various etiologies of small bowel bleeding and a stepwise guide for diagnosing and managing this condition. April 19, 2022 Use of prophylactic clip placement to reduce post-EMR bleeding In this Q&A, Mayo Clinic gastroenterologist Norio Fukami, M.D., discusses the role of prophylactic clip placement in reducing clinically significant post-EMR bleeding. April 19, 2022 Vaccine efficacy and antibody response among patients with IBD and recipients of immunosuppressive agents Studies explore vaccine efficacy, antibody response and other outcomes in individuals with inflammatory bowel disease and patients receiving immune-modifying therapies. Feb. 12, 2022 Role of gut microbiota in obesity and the future of microbiota therapeutics for obesity Mayo Clinic researchers summarize the pathogenesis of obesity, the relationship between gut microbiota and obesity, and the future of microbiota-based therapies in obesity management. Feb. 12, 2022 Survey examines attitudes about ESG from providers around the world A Mayo Clinic survey assessed ESG-related practice trends and preferences of bariatric endoscopists who perform this weight-loss procedure. Feb. 12, 2022 Intrinsic tactile sensitivity within the GI tract linked to the activity of specialized sensory enteroendocrine cells Research demonstrates that specialized sensory cells within the gastrointestinal tract have a lot in common with the way the skin feels the sensation of touch. Feb. 12, 2022 Researchers evaluate endoscopic through-the-scope tack and suture system A multicenter study led by Mayo Clinic physicians demonstrated that the endoscopic through-the-scope tack and suture system is safe and efficient. Jan. 25, 2022 Diagnosis and management of patients with gastroparesis In commentary published in Neurogastroenterology & Motility in 2021, Mayo Clinic gastroenterology researchers identify five high-priority areas that require the attention of researchers in gastroparesis to advance t[...] Jan. 25, 2022 The role of capsule endoscopy in diagnosis and management of inflammatory bowel disease Mayo Clinic gastroenterologists discuss the indications, strengths and limitations of capsule endoscopy in the diagnosis and management of inflammatory bowel disease (IBD). Jan. 25, 2022 Use of antispasmodics for the treatment of abdominal pain Data supporting the use of antispasmodics for the treatment of chronic abdominal pain in patients with disorders of gut-brain interaction (DGBI), including irritable bowel symptom and functional dyspepsia, are limited. Jan. 25, 2022 Examining the clinical presentation and imaging characteristics of cryptogenic multifocal ulcerous stenosing enteritis Research supports that differential diagnosis of short, multifocal small bowel strictures should always include Crohn's disease, NSAID-induced enteropathy and cryptogenic multifocal ulcerous stenosing enteritis (CMUSE).[...] Dec. 20, 2021 Improving implementation of best practice guidelines for colorectal cancer screening A web-based survey tool to assess factors shaping clinician beliefs and behaviors surrounding average-risk colorectal cancer screening strategies provides valid and consistent information about respondents. Aug. 17, 2021 Use of weight-loss pharmacotherapy in patients with cirrhosis and in liver transplant recipients More data is needed to establish the safety and efficacy of these agents in the pretransplant and post-transplant settings. Nov. 02, 2020 Mayo Clinic study finds 1 in 8 patients with cancer harbor inherited genetic mutations The Interrogating Cancer Etiology Using Proactive Genetic Testing (INTERCEPT) study represents the largest known multicenter study of universal testing of patients with cancer. June 16, 2020 Mayo Clinic, NASA team up to test AI algorithm on colorectal cancer A Center for Individualized Medicine algorithm shows potential in detecting spatio-temporal patterns of colorectal cancer progression from tumor snapshots to predict the cancer's evolutionary trajectory. Feb. 20, 2018 Identifying diarrhea caused by bile acid malabsorption Bile acid malabsorption occurs in about one-third of patients diagnosed with irritable bowel syndrome with diarrhea. The serum 7αC4 test and the fecal bile acid excretion test help identify these patients so that [...] Nov. 17, 2017 Use of dietary strategies in treating eosinophilic esophagitis Mayo Clinic gastroenterologist Jeffrey A. Alexander, M.D., explains current research findings and clinical experience related to the use of elimination diets in the treatment of eosinophilic esophagitis. Understanding and managing chronic abdominal bloating and distension Profesionales médicos Digestive Diseases news